Designing Drug Development Programs for Reimbursement Success Guide Designing Drug Development Programs for Reimbursement Success Download the guide to learn how model-informed drug development, QSP, and MBMA help align with…Certara2026 年 5 月 7 日
Population Pharmacodynamic Modeling of Plozasiran for Treatment of Familial Chylomicronemia Syndrome Publication Population Pharmacodynamic Modeling of Plozasiran for Treatment of Familial Chylomicronemia Syndrome A newly approved RNA interference (RNAi) therapy lowers harmful triglyceride (TG) levels in patients with…Certara2026 年 5 月 7 日
Population Pharmacokinetics and Exposure-Response Analysis of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia Patients With NPM1 Mutation Publication Population Pharmacokinetics and Exposure-Response Analysis of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia Patients With NPM1 Mutation This study evaluated how the leukemia drug ziftomenib behaves in the body and whether different…Certara2026 年 5 月 7 日
Population Pharmacokinetic Modeling and Exposure-Response Analyses of Nemtabrutinib in Patients With Hematologic Malignancies Publication Population Pharmacokinetic Modeling and Exposure-Response Analyses of Nemtabrutinib in Patients With Hematologic Malignancies Population pharmacokinetic (PopPK) and exposure-response modeling were used to support the clinical development of nemtabrutinib,…Certara2026 年 5 月 7 日
Optimize Readiness for MHRA-NICE Aligned Pathway Blog Optimize Readiness for MHRA-NICE Aligned Pathway Achieve HTA and regulatory success in the MHRA–NICE pathway through early evidence alignment.Certara2026 年 5 月 1 日
Compliance? Anywhere, anytime: Automated controlled substance detection and tariff classification at Merck KGaA On-Demand Webinar Compliance? Anywhere, anytime: Automated controlled substance detection and tariff classification at Merck KGaA Learn how Merck KGaA automates controlled substance detection and HS classification to ensure global compliance…Certara2026 年 4 月 27 日
DIDB® Concomitant Meds Navigator Fact Sheet DIDB® Concomitant Meds Navigator Explore the Concomitant Meds Navigator withing DIDB - An evidence-based tool within DIDB that helps…Certara2026 年 4 月 27 日
ADC Dose Optimization: Applying Model-Informed Strategies in Development Blog ADC Dose Optimization: Applying Model-Informed Strategies in Development Explore ADC dose optimization using model-informed strategies to balance efficacy and safety across antibody drug…Certara2026 年 4 月 22 日
Extending the Value of Antibody–Drug Conjugates: Model-Informed Labeling, Expansion, and Market Access On-Demand Webinar Extending the Value of Antibody–Drug Conjugates: Model-Informed Labeling, Expansion, and Market Access Learn how model-informed strategies support ADC labeling, dose optimization, and market access through integrated evidence…Certara2026 年 4 月 10 日